Should the Rich Be Allowed to Buy the Best Genes?
By Walter Isaacson,
Air Mail
| 07. 27. 2019
QUEBEC CITY
Biology is the new tech. I’m at a conference in Quebec City on CRISPR, the molecular tool designed to edit genes, and it has the same vibe as the meetings of the Homebrew Computer Club and the West Coast Computer Faire did in the 1970s, except that the hip young innovators are programming with genetic code rather than computer code. Now that schools are finally realizing that every kid should learn how to code, they are going to have to switch from teaching 0101 to A.G.C.T., the four bases of our DNA.
Many of the star pioneers are here, including Berkeley’s Jennifer Doudna, who in 2012 co-discovered how to combine two snippets of RNA with an enzyme to make a programmable scissors that could cut DNA at a precise location, and Feng Zhang of the Broad Institute, who raced her to show how the tool could edit genes in humans and is now in a battle with her for patents to the technology.
The atmosphere is charged with the catalytic combination of competition and cooperation reminiscent of when...
Related Articles
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
By Ryan Cross, Endpoints News | 08.19.2025
Human eggs are incredibly rare cells. The ovary typically produces only 400 mature eggs across a woman’s life. But biologists in George Church’s lab at Harvard University — a group that’s never content with nature’s limits — just got a...
By Katherine Drabiak, Journal of Medical Ethics Forum | 08.07.2025
Adapted from Mitochondrial DNA at
National Human Genome Research Institute
Recently, media outlets around the world have been reporting on children born from pronuclear genome transfer (sometimes called “3-parent IVF,” “mitochondrial donation” or “mitochondrial replacement therapy”) at Newcastle Fertility Center...
By Nicky Hudson, The Conversation | 08.12.2025
